Previous observations endorse this hypothesis: SLE patients display multiple signaling defects leading to a defective IL-2 production [37], and CD4+FOXP3+ thymocytes from IL-2-/- mice have very few cells expressing CD25 when compared to wild type mice [38]. Here, IL2 is linked to systemic lupus erythematosus.